Atlas Trials

A Study of Patient Characteristics, Treatment Patterns and Outcomes Among Patients Treated With 177Lu-PSMA-617

Clinical trial NCT07450157 · COMPLETED

Trial details

NCT number
NCT07450157
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Study type
OBSERVATIONAL
Prostate Cancer
Start date
2023-06-23
Primary completion
2025-02-28
Enrollment
6448

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.